Press Releases April 28, 2026 06:30 AM

BOSS Zhipin's Ongoing Share Repurchases Reach Nearly RMB1.07 Billion in 2026

KANZHUN LIMITED Continues Aggressive Share Buyback Program, Spending Nearly RMB1.07 Billion in 2026

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
BZ

KANZHUN LIMITED (traded as BZ on Nasdaq) has continued its share repurchase program with a recent buyback of approximately RMB27.3 million for 588,046 shares. The company has consistently repurchased shares for 26 trading days and has spent nearly RMB1.07 billion on buybacks so far in 2026, signaling strong commitment to enhancing shareholder value.

BOSS Zhipin's Ongoing Share Repurchases Reach Nearly RMB1.07 Billion in 2026
BZ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • KANZHUN LIMITED has repurchased shares for 26 consecutive trading days in 2026.
  • The company has spent nearly RMB1.07 billion on share repurchases year-to-date.
  • The latest buyback involved approximately RMB27.3 million for 588,046 ordinary shares.

BEIJING, April 28, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing around RMB27.3 million to repurchase 588,046 ordinary shares on April 27. With this latest transaction, the Company has made repurchases for the past 26 consecutive trading days, deploying nearly RMB1.07 billion toward share repurchases year-to-date in 2026. This effort underscores the Company's ongoing commitment to delivering value to shareholders.


Risks

  • Continued large share buybacks may strain company cash reserves or impact liquidity.
  • Market or regulatory changes could affect the ability to continue share repurchases.
  • Share repurchase programs may not lead to sustained stock price appreciation if company fundamentals deteriorate.

More from Press Releases

VirTra Wins Five-Year CBP Contract With Up to $14 Million in Potential Value Oct 6, 2026 Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal Oct 6, 2026 YSX TECH. CO. LTD to Hold Extraordinary General Meeting of Shareholders Oct 5, 2026 Blaize Provides Preliminary Third Quarter 2026 Revenue Update and Full-Year Guidance Update Oct 5, 2026 Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock Oct 5, 2026